Asymmetrical Ocular Manifestations of Nephropathic Cystinosis; A Case Report

Patient: Female, 22 Final Diagnosis: Nephrogenic cystinosis Symptoms: Bilateral eye pain Medication: — Clinical Procedure: — Specialty: Ophthalmology Objective: Rare co-existance of disease or pathology Background: Infantile nephropathic cystinosis is the most common and severe variant of cystinosis, which is a rare autosomal recessive condition related to a defect in the transportation of the protein cystine resulting in its deposition in various organs. Due to the rarity of this condition, only 1 case with extensive ocular involvement has been found in the English-language literature. Here, we report a second such case to highlight the significance of early diagnosis in avoiding devastating but preventable vision loss. Case Report: We describe the extensive asymmetrical ocular involvement in a 22-year-old woman who had nephropathic cystinosis since childhood. Despite frequent follow up and systemic and topical cysteamine therapy, she developed ocular complications, including increased intraocular pressure, uveitis, and retinal changes with complete loss of vision in her left eye. In addition, her general condition requires a renal transplant in the near future. Conclusions: Ophthalmologists should be aware of cystinosis and the sequalae of ocular involvement in this disease, despite its rarity. Identification of the earliest corneal deposits should not be overlooked, especially in the context of other systemic manifestations that are indicative of the nephropathic variant of cystinosis.

[1]  Achini K. Makuloluwa,et al.  Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review , 2018, Clinical ophthalmology.

[2]  C. Baudouin,et al.  A New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study. , 2017, Investigative ophthalmology & visual science.

[3]  L. P. Van den Heuvel,et al.  Cystinosis: a review , 2016, Orphanet Journal of Rare Diseases.

[4]  K. Ramaesh,et al.  Treatment of corneal cystine crystal accumulation in patients with cystinosis , 2014, Clinical ophthalmology.

[5]  D. Trauner,et al.  Nephropathic cystinosis: an international consensus document. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  G. Deschênes,et al.  A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: the Cystadrops OCT-1 study. , 2014, Molecular genetics and metabolism.

[7]  C. Antignac,et al.  Clinical utility gene card for: Cystinosis , 2013, European Journal of Human Genetics.

[8]  C. Antignac,et al.  Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults. , 2012, Kidney international.

[9]  C. Bassim,et al.  Craniofacial and dental findings in cystinosis. , 2010, Oral diseases.

[10]  P. Niaudet,et al.  In vivo confocal microscopy and anterior segment optical coherence tomography analysis of the cornea in nephropathic cystinosis. , 2009, Ophthalmology.

[11]  W. Gahl,et al.  Nephropathic Cystinosis in Adults: Natural History and Effects of Oral Cysteamine Therapy , 2007, Annals of Internal Medicine.

[12]  D. Trauner,et al.  Non‐verbal deficits in young children with a genetic metabolic disorder: WPPSI‐III performance in cystinosis , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[13]  W. Gahl,et al.  Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature. , 2007, Survey of ophthalmology.

[14]  M. Kaiser-Kupfer,et al.  Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy. , 2006, Ophthalmology.

[15]  C. Antignac,et al.  Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosin. , 2004, Human molecular genetics.

[16]  M. Kaiser-Kupfer,et al.  Age-Related Prevalence of Anterior Segment Complications in Patients With Infantile Nephropathic Cystinosis , 2002, Cornea.

[17]  E. Kuehl,et al.  Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. , 2000, Molecular genetics and metabolism.

[18]  O. Gribouval,et al.  A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis , 1998, Nature Genetics.

[19]  W. Gahl,et al.  Pituitary-Testicular Function in Nephropathic Cystinosis , 1993, Annals of Internal Medicine.

[20]  E. Kuehl,et al.  A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis. , 1990, Archives of ophthalmology.

[21]  M. Kaiser-Kupfer,et al.  Long-term ocular manifestations in nephropathic cystinosis. , 1986, Archives of ophthalmology.